EIF2A and head and neck squamous cell carcinoma: Intriguingly, reduction of MT dose from 5 mM to 0.5 mM did not activate eIF2α-ATF4 axis and altered FGF19 protein levels in all three HNSCC cells (Fig. 2a), suggesting that only high-dose MT can induce FGF19 upregulation.